Quarterly report · Q2
8938.TEDINET S100OHWS
Period2021-04-01 → 2021-09-30
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100MTSB.
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2020-04-01 → 2020-09-30 | Cons. | Net sales |
| Operating income | ¥132m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Operating income | ¥105m | 2020-04-01 → 2020-09-30 | Cons. | Operating income |
| Ordinary income | ¥144m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥46m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥236m | 2020-04-01 → 2020-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥140m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥243m | 2020-04-01 → 2020-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥110m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥255m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥281m | 2020-04-01 → 2020-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥110m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Net income | −¥281m | 2020-04-01 → 2020-09-30 | Cons. | Profit loss |
| Total assets | ¥8.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥9.1bn | at 2020-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2021-09-30 | Cons. | Liabilities |
| Total liabilities | ¥962m | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.5bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2020-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.1bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2020-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥945m | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥250m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥6m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥695m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥320m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥213m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥12.2 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.74 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-38.82 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-50.66 | 2020-04-01 → 2020-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.25 | 2020-07-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥12.19 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 87.3% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.3% | at 2020-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 31
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥208m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥921m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥921m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥246m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥237m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥237m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥94m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥341m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥341m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2020-09-30 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2020-09-30 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2020-09-30 | −¥235m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥724m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥724m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥190m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥5m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥150m |
| —segment total | revenue | 2020-04-01 → 2020-09-30 | ¥2.2bn |
| —segment total | revenue external | 2020-04-01 → 2020-09-30 | ¥2.2bn |
| —segment total | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥5m |
| —segment total | segment profit | 2020-04-01 → 2020-09-30 | ¥340m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2020-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2020-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2020-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2020-09-30 | ¥340m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest income noi | Prior1YTDDuration | 118000000 | JPY |
| Interest income noi | CurrentYTDDuration | 2000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | － | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 38000000 | JPY |
| Reversal of bonus reserve noi | Prior1YTDDuration | 32000000 | JPY |
| Reversal of bonus reserve noi | CurrentYTDDuration | － | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 41000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | － | JPY |
| Other noi | Prior1YTDDuration | 5000000 | JPY |
| Other noi | CurrentYTDDuration | 4000000 | JPY |
| Non operating income | Prior1YTDDuration | 198000000 | JPY |
| Non operating income | CurrentYTDDuration | 45000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 87000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 2000000 | JPY |
| Provision of allowance for doubtful accounts noe | Prior1YTDDuration | 74000000 | JPY |
| Provision of allowance for doubtful accounts noe | CurrentYTDDuration | － | JPY |
| Financing expenses noe | Prior1YTDDuration | 33000000 | JPY |
| Financing expenses noe | CurrentYTDDuration | 24000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 329000000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | － | JPY |
| Other noe | Prior1YTDDuration | 14000000 | JPY |
| Other noe | CurrentYTDDuration | 5000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 539000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 33000000 | JPY |
| Ordinary income | Prior1YTDDuration | -236000000 | JPY |
| Ordinary income | CurrentYTDDuration | 144000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | Prior1YTDDuration | 61000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | CurrentYTDDuration | － | JPY |
| Insurance income ei | Prior1YTDDuration | － | JPY |
| Insurance income ei | CurrentYTDDuration | 10000000 | JPY |
| Other ei | Prior1YTDDuration | 9000000 | JPY |
| Other ei | CurrentYTDDuration | － | JPY |
| Extraordinary income | Prior1YTDDuration | 70000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 10000000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 1000000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 0 | JPY |
| Special audit fees el | Prior1YTDDuration | 12000000 | JPY |
| Special audit fees el | CurrentYTDDuration | － | JPY |
| Loss on valuation of investments in capital el | Prior1YTDDuration | 48000000 | JPY |
| Loss on valuation of investments in capital el | CurrentYTDDuration | 0 | JPY |
| Increase in provision for loss on liquidation of subsidiaries and affiliated companies el | Prior1YTDDuration | － | JPY |
| Increase in provision for loss on liquidation of subsidiaries and affiliated companies el | CurrentYTDDuration | 8000000 | JPY |
| Impairment loss el | Prior1YTDDuration | － | JPY |
| Impairment loss el | CurrentYTDDuration | 3000000 | JPY |
| Other el | Prior1YTDDuration | 8000000 | JPY |
| Other el | CurrentYTDDuration | 0 | JPY |
| Extraordinary loss | Prior1YTDDuration | 70000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 14000000 | JPY |
| Income before dividends distribution from silent partnership income taxes | Prior1YTDDuration | -235000000 | JPY |
| Income before dividends distribution from silent partnership income taxes | CurrentYTDDuration | 140000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |